Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Browse by Journal Title

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type
Jump to: 2023 | 2022 | 2020 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013

2023

Beta cell dysfunction induced by bone morphogenetic protein (BMP)-2 is associated with histone modifications and decreased NeuroD1 chromatin binding.
Urizar, A.I. and Prause, M. and Ingerslev, L.R. and Wortham, M. and Sui, Y. and Sander, M. and Williams, K. and Barrès, R. and Larsen, M.R. and Christensen, G.L. and Billestrup, N.
Cell Death & Disease 14 (7): 399. 5 July 2023

2022

Hydroxylation of the NOTCH1 intracellular domain regulates Notch signaling dynamics.
Ferrante, F. and Giaimo, B.D. and Friedrich, T. and Sugino, T. and Mertens, D. and Kugler, S. and Gahr, B.M. and Just, S. and Pan, L. and Bartkuhn, M. and Potente, M. and Oswald, F. and Borggrefe, T.
Cell Death & Disease 13 (7): 600. 12 July 2022

2020

Galectin-3 deficiency in pregnancy increases the risk of fetal growth restriction (FGR) via placental insufficiency.
Freitag, N. and Tirado-Gonzalez, I. and Barrientos, G. and Powell, K.L. and Boehm-Sturm, P. and Koch, S.P. and Hecher, K. and Staff, A.C. and Arck, P.C. and Diemert, A. and Blois, S.M.
Cell Death & Disease 11 (7): 560. 23 July 2020

2018

Pan-class I  PI3-kinase inhibitor BKM120 induces MEK1/2-dependent mitotic catastrophe in non-Hodgkin lymphoma leading to apoptosis or polyploidy determined by Bax/Bak and p53.
Müller, A. and Gillissen, B. and Richter, A. and Richter, A. and Chumduri, C. and Daniel, P.T. and Scholz, C.W.
Cell Death & Disease 9 (3): 384. 7 March 2018

Lenalidomide regulates CNS autoimmunity by promoting M2 macrophages polarization.
Weng, Q. and Wang, J. and Wang, J. and Wang, J. and Sattar, F. and Zhang, Z. and Zheng, J. and Xu, Z. and Zhao, M. and Liu, X. and Yang, L. and Hao, G. and Fang, L. and Lu, Q.R. and Yang, B. and He, Q.
Cell Death & Disease 9 (2): 251. 14 February 2018

EGFR activation triggers cellular hypertrophy and lysosomal disease in NAGLU-depleted cardiomyoblasts, mimicking the hallmarks of mucopolysaccharidosis IIIB.
De Pasquale, V. and Pezone, A. and Sarogni, P. and Tramontano, A. and Schiattarella, G.G. and Avvedimento, V.E. and Paladino, S. and Pavone, L.M.
Cell Death & Disease 9 (2): 40. 18 January 2018

2017

Neuroblastoma cells depend on HDAC11 for mitotic cell cycle progression and survival.
Thole, T.M. and Lodrini, M. and Fabian, J. and Wuenschel, J. and Pfeil, S. and Hielscher, T. and Kopp-Schneider, A. and Heinicke, U. and Fulda, S. and Witt, O. and Eggert, A. and Fischer, M. and Deubzer, H.E.
Cell Death & Disease 8 (3): e2635. 2 March 2017

2016

CD95 maintains stem cell-like and non-classical EMT programs in primary human glioblastoma cells.
Drachsler, M. and Kleber, S. and Mateos, A. and Volk, K. and Mohr, N. and Chen, S. and Cirovic, B. and Tuettenberg, J. and Gieffers, C. and Sykora, J. and Wirtz, C.R. and Mueller, W. and Synowitz, M. and Martin-Villalba, A.
Cell Death & Disease 7 : e2209. 28 April 2016

2015

Chloride transporter KCC2-dependent neuroprotection depends on the N-terminal protein domain.
Winkelmann, A. and Semtner, M. and Meier, J.C.
Cell Death & Disease 6 : e1776. 4 June 2015

How cell death shapes cancer.
Labi, V. and Erlacher, M.
Cell Death & Disease 6 : e1675. 5 March 2015

Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation.
Rettig, I. and Koeneke, E. and Trippel, F. and Mueller, W.C. and Burhenne, J. and Kopp-Schneider, A. and Fabian, J. and Schober, A. and Fernekorn, U. and von Deimling, A. and Deubzer, H.E. and Milde, T. and Witt, O. and Oehme, I.
Cell Death & Disease 6 : e1657. 19 February 2015

2014

The traditional Chinese medical compound Rocaglamide protects nonmalignant primary cells from DNA damage-induced toxicity by inhibition of p53 expression.
Becker, M.S. and Schmezer, P. and Breuer, R. and Haas, S.F. and Essers, M.A. and Krammer, P.H. and Li-Weber, M.
Cell Death & Disease 5 : e1000. January 2014

2013

Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance in carcinoma by switching apoptosis signaling to a Bax/Bak-independent 'type I' mode.
Gillissen, B. and Richter, A. and Richter, A. and Overkamp, T. and Essmann, F. and Hemmati, P.G. and Preissner, R. and Belka, C. and Daniel, P.T.
Cell Death & Disease 4 : e643. 23 May 2013

Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma.
Kocak, H. and Ackermann, S. and Hero, B. and Kahlert, Y. and Oberthuer, A. and Juraeva, D. and Roels, F. and Theissen, J. and Westermann, F. and Deubzer, H. and Ehemann, V. and Brors, B. and Odenthal, M. and Berthold, F. and Fischer, M.
Cell Death & Disease 4 : e586. 11 April 2013

This list was generated on Thu Apr 25 02:32:32 2024 CEST.
Open Access
MDC Library